US Bancorp
NAGE

US Bancorp’s Niagen Bioscience NAGE Stock Holding History

US Bancorp’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653 Hold
148
– – ﹤0.01% 3978
2025
Q4 		$941 Sell
148
-36
-20% -$250 ﹤0.01% 3861
2025
Q3 		$1.72K Buy
184
+15
+9% +$151 ﹤0.01% 3774
2025
Q2 		$2.44K Buy
169
+148
+705% +$1.46K ﹤0.01% 3827
2025
Q1 		$145 Buy
+21
New +$132 ﹤0.01% 4119
2017
Q1 		– Sell
-22,634
Closed -$75K – 3652
2016
Q4 		$75K Hold
22,634
– – ﹤0.01% 2250
2016
Q3 		$67K Buy
+22,634
New +$83.1K ﹤0.01% 2291

Other funds holding NAGE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return